The QualityStocks Daily Thursday, March 12th, 2020

Today's Top 3 Investment Newsletters

StockMarketWatch (DSS) +80.31%

QualityStocks (DXIEF) +78.79%

NetworkNewsWire (XALL) +75.00%

The QualityStocks Daily Stock List

ALX Resources Corp. (ALXEF)

Resource Stock Digest, Mining Stock Education, FSCWire, OTC Markets, Market Screener, Nasdaq, Stockwatch, Ceo.ca, Investing News, MarketWatch, DigiGeoData, InvestorsHub, The Gold Telegraph, Morningstar and Stockhouse reported earlier on ALX Resources Corp. (ALXEF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

ALX Resources Corp. explores a portfolio of prospective mineral properties that include nickel copper-cobalt, gold and uranium. Recently, the Company acquired the Falcon Nickel and Flying Vee Nickel projects in northern Saskatchewan; the Vixen Gold Project in the historic Red Lake Mining District of Ontario; and the Draco VMS Project in Norway. Incorporated in 2007, ALX Resources has its corporate headquarters in Vancouver, British Columbia. The Company previously went by the name ALX Uranium Corp. It changed its name to ALX Resources Corp. in January of this year.

The Falcon Nickel Project consists of 67 claims owned 100 percent by ALX totaling 20,002 hectares (49,427 acres). These are prospective for nickel, copper and cobalt (Ni-Cu-Co) mineralization, situated in the northern Athabasca region of Saskatchewan. Falcon hosts a magmatic nickel-sulphide mineralizing system that has been underexplored by contemporary methods until its acquisition by ALX Resources. The Flying Vee project comprises 13 claims totaling 27,055.98 hectares. ALX Resources owns a 100 percent interest in the property. Flying Vee is prospective for nickel, copper and cobalt mineralization and encompasses the historical Reeve Lake nickel showing and drill hole intersection. In 2018, the Company initiated staking in the Flying Vee region through acquiring five claims and added eight new claims in April 2019 after a staking rush was triggered in the region by an emerging battery metals company (Kobold Metals).

This past October, ALX Resources announced the acquisition of mineral claims prospective for copper-zinc-gold-silver mineralization at its 100 percent-owned Draco VMS Project in the Grong district of central Norway. In May of 2019, ALX staked 10 claims totaling roughly 5,959 hectares following its study of surface mineral showings integrated with historical airborne survey data that identified trends that could represent zones of volcanogenic massive sulfide (VMS) style mineralization.

The Tango property comprises eight claims owned 100 percent by ALX Resources totaling 13,709 hectares. The Tango property lies in the Mudjatik Domain in a region that is prospective for nickel, copper and cobalt mineralization. Based on prior exploration, the Tango property has the potential to host polymetallic mineral deposits.

On September 26, 2019, ALX Resources announced the acquisition of claims prospective for gold mineralization in the Red Lake Mining District of Ontario. The Vixen Gold Project comprises three sub-projects totaling 10,008 hectares (27,730 acres) staked within the Birch-Uchi greenstone belt, positioned about 60 kilometres (37 miles) east of Red Lake, Ontario. Vixen is owned 100 percent by ALX, subject to a 2.0 percent Net Smelter Returns royalty (NSR).

ALX Resources also has a number of Uranium projects. These are Close Lake, Hook-Carter, Black Lake, Newnham Lake, Kelic Lake, Gibbons Creek, Lazy Edward Bay, Carpenter Lake, Perch, the Cluff Lake Properties (Bridle & Middle Lakes), and South Pine. New Uranium projects include the Argo, Vulcan, Sabre, and Luna projects.

This month, ALX Resources announced that drilling started at its 100 percent-owned Falcon Nickel Project. A helicopter-supported diamond drilling program of up to 1,000 meters in 4 to 5 holes is taking place. The Company's first drill hole of the 2020 program is in progress on the V-1 conductive target (V-1) at the historical Currie Lake deposit area.

ALX Resources Corp. (ALXEF), closed Thursday's trading session at $0.0125, off by 60.9375%, on 27,520 volume with 5 trades. The average volume for the last 3 months is 12,612 and the stock's 52-week low/high is $0.0125/$0.057999998.

chart

Cordoba Minerals Corp. (CDBMF)

OTC Markets, Equities, Stock Day Media, Mining Stock Valuator, Investing News, Morningstar, Proactive Investors, Investor Ideas, Stockhouse, Dividend.com, OTC.Watch, Investors Hangout, Seeking Alpha, Nasdaq, Geology for Investors, Wallet Investor, Northern Miner, Macroaxis, GlobeNewswire, Dividend Investor, YCharts, Market Screener, MarketWatch, Junior Mining Network and Stockwatch reported previously on Cordoba Minerals Corp. (CDBMF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Cordoba Minerals Corp. is a mineral exploration company focused on the exploration, development and acquisition of copper and gold projects. It is exploring the San Matias Copper-Gold-Silver Project. This Project includes the Alacran deposit and satellite deposits at Montiel East, Montiel West and Costa Azul, located in the Department of Cordoba, Colombia. Incorporated in 2009, and OTCQB-listed, Cordoba Minerals is headquartered in Vancouver, British Columbia.

Cordoba also holds a 25 percent interest in the Perseverance porphyry copper project in Arizona that it is exploring by way of a Joint Venture (JV) and Earn-In Agreement. In July 2017, the Company acquired a 100 percent ownership interest in the San Matias Copper-Gold-Silver Project from High Power Exploration, Inc. (HPX). HPX is a privately owned, metals-focused exploration company led by mining entrepreneur Mr. Robert Friedland. HPX owns a roughly 70 percent interest in Cordoba Minerals.

The San Matias Copper-Gold-Silver Project comprises a 20,000 hectare land-package. It contains several known areas of porphyry copper-gold and iron oxide copper gold, and/or carbonate replacement deposit mineralization and gold veins. The Project is close to sea-level in an established mining district with premier access and infrastructure.

The San Matias Project is an early stage exploration project. Cordoba Minerals is exploring a newly identified high grade copper-gold district. This district is characterized by porphyry type and “carbonate replacement” (CRD) type and/or “iron oxide copper-gold” (IOCG) type deposits formed in an accreted island arc setting.

This past January, Cordoba Minerals announced its upcoming work program for 2020 at the San Matias Copper-Gold-Silver Project in Colombia and the Perseverance Copper Project in Arizona. Mr. Eric Finlayson, President and Chief Executive Officer of Cordoba and President of Cordoba's majority shareholder High Power Exploration (HPX), said, "At San Matias, which has been designated as a project of national significance by the Government of Colombia, we are conducting pre-feasibility studies for mine development at the Alacran copper-gold-silver deposit while continuing the search for the concealed porphyry systems responsible for mineralization in the area. At Perseverance, together with our joint venture partner Bell Copper, we hope to definitively test the porphyry copper potential of the project in 2020."

Last month, Cordoba Minerals announced that at the Special Meeting of Shareholders held on February 12, 2020, Shareholders voted to increase the number of Directors to six and elected Mr. Luis Valencia Gonzales as a Director of the Company to fill the vacancy created by the increase. Mr. Gonzales will hold such office until Cordoba Minerals’ next annual general meeting.

Cordoba Minerals Corp. (CDBMF), closed Thursday's trading session at $0.037, off by 32.7273%, on 47,707 volume with 8 trades. The average volume for the last 3 months is 19,744 and the stock's 52-week low/high is $0.02666/$0.100000001.

chart

Halo Labs, Inc. (AGEEF)

Hot Stocks Review, Market Screener, TeleTrader, InvestorsHub, MarketWatch, Street Insider, Value The Markets, NIC Investors, Small Cap Power, Green Market Report, Midas Letter, wallstreet-online, New Cannabis Ventures, Investing News, TMXmoney, Morningstar, OTC Markets, Stockhouse, and Stockwatch reported previously on Halo Labs, Inc. (AGEEF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Halo Labs, Inc. is a cannabis extraction company based in Toronto, Ontario. It develops and manufactures quality cannabis oils and concentrates. Currently, the Company is operating in California and Oregon, as well as in Nevada with its partner Just Quality, LLC, and in Lesotho with the Bophelo strategic partnership (within a planned 205-hectare cultivation zone via Bophelo). Furthermore, it earlier acquired Dispensary Track platform, which will ease customer flow constraints experienced by dispensaries and enable direct consumer interaction. Halo Labs’ shares trade on the OTC Markets Group’s OTCQX.

Fundamentally, Halo Labs is a leader in cannabis extraction utilizing proprietary science based techniques and developing inventive products. The Company is at the vanguard of modern cannabis extraction techniques and cannabinoid isolation. Halo Labs possesses proprietary trade secrets and leading-edge technology that is setting the standard in a new and thriving industry.

Halo Labs develops brands and provides white label manufacturing. Pertaining to areas of operation, the Company was founded in Oregon and is expanding to Nevada and California. It is developing brands for each segment of the market.

This includes Ultra-Premium; Premium-Oregon; Edibles-Oregon; Mainstream-Oregon; Mainstream-Nevada; and Everyday Value. In Oregon, Halo Labs has a 12,000 sq. ft. manufacturing facility in Medford, and 6 acres of outdoor canopy in Jackson County. For Hemp in Oregon, it has 7,500 sq. ft. purpose-built hemp manufacturing in Trent.

In Nevada, the Company has an 8,000 sq. ft. licensed processing facility by the Las Vegas Airport. Halo has 1,400 units per day estimated production capacity from its current 2,000 sq. ft. of operations.

In California, it has 15,520 sq. ft. of licensed volatile & non-volatile processing facilities in Cathedral City. Halo has 5 contracts signed with Falcon International, Caliva, Nectar and Ikanik Farms. Halo has 12,000 grams per day estimated present production capacity from Facility 1. Moreover, the Company has distribution partnerships with C4 Distro to deliver to 260 dispensaries in Southern California and Nabis who penetrates 99 percent of the California market.

Halo Labs recently entered into binding agreements to acquire a dispensary in Los Angeles, 3 KushBar branded dispensaries, 5 development permits in Alberta, and Canmart Limited that holds wholesale distribution and special licenses permitting the import and distribution of cannabis based products for medicinal use (CBPM’s) in the UK.

Halo Labs, Inc. (AGEEF), closed Thursday's trading session at $0.095, off by 26.6409%, on 748,154 volume with 255 trades. The average volume for the last 3 months is 322,084 and the stock's 52-week low/high is $0.065999999/$0.669399976.

chart

Jushi Holdings, Inc. (JUSHF)

NetworkNewsWire, InvestorX, OTC Markets, Barchart, Street Insider, Wallmine, OTC.Watch, Stockhouse, Penny Stock Hub, New Cannabis Ventures, Stock Digest, Cannabis Daily, Corporate Knights, Green Market Report, NIC Investors, Cannabis News Wire, BioSpace, Stockwatch, Energy and Capital, Investing News, PR Newswire, and Market Wire News reported beforehand on Jushi Holdings, Inc. (JUSHF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Jushi Holdings, Inc. is an internationally-focused, multi-state cannabis and hemp operator. The Company is focused in the United States on building a multi-state portfolio of branded cannabis and hemp-derived assets through opportunistic acquisitions, distressed workouts and competitive applications. Formed in 2018, Jushi Holdings is based in Boca Raton, Florida. The Company’s shares trade on the OTC Markets Group’s OTCQX.

Jushi’s mission is to create an integrated global community of wellness, mindfulness, and connections via superior quality cannabis and hemp-derived products. Its brands include Beyond/Hello, Nira, The Lab, and The Bank. Beyond/Hello is a brand of cannabis dispensaries. Nira is a new line of hemp-based CBD (cannabidiol) products that are physician-formulated and produced with full-spectrum hemp. Nira products are developed under the guidance of Dr. Laszlo Mechtler, MD, FAAN, FASN, FEAN, Professor of Neurology Oncology.

The Lab infused production facility has been in operation since 2010. Currently, the Lab is producing greater than one million grams of concentrate across 70-plus product formulations in a calendar year. The Bank genetics has been producing first-rate cannabis seeds and flower for the past decade.

Last week, Jushi Holdings announced that one of its two newly acquired Illinois dispensaries, presently operating as The Green Solution and transitioning to Jushi’s BEYOND/HELLO brand later in 2020, opened for adult-use cannabis sales on March 2, 2020. This dispensary is located at 2021 Goose Lake Road, Sauget, Illinois 62206. It will be open from 9 a.m. – 7 p.m. Monday through Saturday and closed on Sunday, offering medical and adult-use cannabis and cannabis products.

Additionally, last week, Jushi Holdings announced the appointment of Andreas Neumann as Chief Creative Director, who will be joined by Julian Scaff as Experience Director and Benjamin McAllister as Art & Digital Director. Furthermore, Michael Perlman has been appointed as Executive Vice President of Investor Relations & Treasurer.

Jushi Holdings, Inc. (JUSHF), closed Thursday's trading session at $0.95, off by 8.6538%, on 156,442 volume with 79 trades. The average volume for the last 3 months is 39,761 and the stock's 52-week low/high is $0.25999999/$2.51810002.

chart

Nocera, Inc. (NCRA)

OTC Markets, Accesswire, Equities, Stock Scores, Stock Pulse, Emerging Growth, Stockwatch, Morningstar, GuruFocus, Nasdaq, Simply Wall St, Wallet Investor, TradingView, last10k, Dividend.com. YCharts, investorBASE, Whale Wisdom, Stockopedia, PR Newswire, Big News Network, InvestorsHub, and Pink Investing reported beforehand on Nocera, Inc. (NCRA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Nocera, Inc. is a provider of design, build, and installation services of aquaculture (fish farm) equipment. Furthermore, the Company provides technical assistance to the operators of the equipment. Nocera operates largely through its Grand Smooth, Inc. subsidiary. Nocera has its corporate office in Atlanta, Georgia.

Nocera’s first-generation RAS (Recirculating Aquaculture Systems) container system was introduced as a new and very simple way for local fish farmers to breed fish in Xing Yi, a city of Guizhou, China. In 2018, the Company accomplished the development of its 2nd generation RAS cylindrical tank system. This system produces greater than two times of fish harvest of container system per annum. Nocera has strategically partnered with CIMC to launch 4 new sites employing its 2nd generation RAS in Guizhou.

Nocera’s Land-Based RAS can be used for saltwater and freshwater species. The RAS systems recycle water, and in the process help preserve the ecosystem through lessening pollution from an over concentration of fish in natural waterways or bodies. The Company’s RAS tanks can produce up to 20,000-30,000 lbs. of fish each year.

Nocera’s plan is to expand its services outside of China, such as Taiwan, the United States, Japan, and Thailand, through building its land-based RAS demo sites and fish farms. These promote the environmental benefits of its land-based RAS and let the public participate in its fish farming business.

During Q4 of 2019, Nocera announced a Regional Agency Cooperation (Marketing) Agreement with JC Development, Ltd. covering the Asian region. In addition, in Q4 2019, Nocera signed an agreement to produce 400 tank systems for Dongguan CIMC Intelligent Technology Co., Ltd. (DG CIMC).

This past January, Nocera announced that it entered into a Project Contract with Procare International Co., Ltd. to produce 6,500 Recirculating Aquaculture System (RAS) for a RAS fish farm development in Ru Hu, Guang Dong province. The expectation is that the production and installation of the 6,500 RAS tanks will commence late in Q1 of 2020, and extend over a three year time period. Based upon the present exchange rates, each tank has a contract value of roughly $18,000; with the estimated total contract value of roughly $117,000,000 over three years.

Nocera, Inc. (NCRA), closed Thursday's trading session at $3.49, up 30.7116%, on 400 volume with 4 trades. The average volume for the last 3 months is 409 and the stock's 52-week low/high is $0.469999998/$5.50.

chart

Rockcliff Metals Corporation (SVVZF)

Stockhouse, Morningstar, Nasdaq, Seeking Alpha, TradingView, GuruFocus, OTC Markets, Wallet Investor, Street Insider, FSCWire, Stockwatch, Dividend Investor, 4-Traders, MarketWatch and Barchart reported previously on Rockcliff Metals Corporation (SVVZF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Rockcliff Metals Corporation is a resource development and exploration company based in Sudbury, Ontario. It is building a copper mining company in the largest VMS (Volcanogenic Massive Sulphide) district globally. In addition to the extensive base metal portfolio of properties, Rockcliff has consolidated the highest grade gold properties in Manitoba’s first gold mining camp situated in Snow Lake, Manitoba. The Company previously went by the name Rockcliff Copper Corporation. It changed its name to Rockcliff Metals Corporation in November of 2017.

Rockcliff Metals has a fully functional +1,000 tpd leased processing and tailings facility and a number of advance-staged, high-grade copper and zinc dominant VMS deposits in the Snow Lake area of central Manitoba. Rockcliff is a major landholder in the Flin Flon-Snow Lake greenstone belt. This belt is home to the largest Paleoproterozoic VMS district in the world, hosting mines and deposits containing copper, zinc, gold and silver. The Company’s broad portfolio of properties totals greater than 4,500 square kilometers. It includes eight of the highest-grade, undeveloped VMS deposits in the belt.

Rockcliff Metals’ projects include the Tower Property, the Talbot Property, the Rail Property, and Bucko Mill. Situated 130 kilometers from the Bucko Mill, the 100 percent-owned Tower Property totals 9,530 hectares and hosts the high-grade copper deposit. It comprises 1.08 million tonnes NI 43-101 Indicated mineral resource grading 3.73% Cu, 1.05% Zn, 0.55 g/t Au and 17.28 g/t Ag, plus a 1.25 million tonne NI 43-101 Inferred mineral resource grading 2.0% Cu, 1.02% Zn, 0.27 g/t Au and 9.78 g/t Ag.

Situated roughly 50 kilometers north of Grand Rapids and roughly 160 kilometers from the Bucko Mill, the Talbot Property is Rockcliff Metals’ flagship gold-rich copper asset. Within the property, the Talbot Deposit hosts a NI 43-101 inferred mineral resource of 4.2 million tonnes at 1.6% Cu, 1.8 g/t Au, 1.4% Zn, 28 g/t Ag.

Positioned 185 kilometers from the Bucko Mill, the 100 percent-owned, near-surface Rail copper deposit has 61 drill holes (+15,000 meters) completed. It is one of the strategic deposits that could be developed in the near term to feed the centralized processing Bucko Mill facility.

Rockcliff Metals controls a 7-year processing lease of the Bucko Mill and tailing storage facilities at the Bucko Lake Mine from CANickel Mining Limited close to Wabowden, central Manitoba. The mill, initially designed for nickel, would be re-developed into a copper processing mill by Rockcliff in the short term.

In Q2 of this year, the Company will complete metallurgical optimization studies to establish required design change to convert the mill into a copper processor. By Q3 of this year, Rockcliff aims to complete establishing cost of conversion to copper processor and make a production decision.

Last week, Rockcliff Metals provided an updated Mineral Resource Estimate on its 100 percent owned Tower Property in central Manitoba. Highlights of the Tower Mineral Resource Update versus prior resource and expansion potential include the Indicated grade increasing by 28 percent; the Indicated contained metal content increased by 21 percent.

The Company is now drilling 750 meters of strike length from the Tower Deposit to the highly prospective Tower South Anomaly, not included in this Mineral Resource update. The Tower Deposit remains open along strike and at depth.

Rockcliff Metals Corporation (SVVZF), closed Thursday's trading session at $0.0436, even for the day, on 96 volume. The average volume for the last 3 months is 10,598 and the stock's 52-week low/high is $0.019999999/$0.122000001.

chart

Worlds, Inc. (WDDD)

InvestorsHub, hot Stocked, Market Wire News, Stockhouse, Market Screener, YCharts, CSI Market, Nasdaq, GlobeNewswire, Investor Village, Wallet Investor, GuruFocus, Stockopedia, Dividend Investor, Insider Financial, Dividend.com, Investors Hangout, StockInvest.us, TradingView, Simply Wall St, Morningstar and Seeking Alpha reported earlier on Worlds, Inc. (WDDD), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Worlds, Inc. is a foremost intellectual property (IP) developer and licensee of patents related to three-dimensional (3D) online virtual worlds. It has a portfolio of 10 U.S. patents for multi-server technology for 3D applications. The Company designs and develops software, content, and related technology for the creation of interactive 3D Internet Websites. The design of its 3D Internet sites are to enable visitation by users through providing them with online communities featuring diverse content, information content, as well as interactive capabilities. OTCQB-listed, Worlds is based in Brookline, Massachusetts.

The earliest of the Company’s patents issued on an application filed November 12, 1996. A provisional patent application, serial number 60/020,296, was filed on November 13, 1995. These patents are related to each other. They disclose and claim systems and methods for enabling users to interact in a virtual space.

Worlds, Inc. (formerly known as Worlds.com, Inc.) was founded in 1994. The Company has developed patented 3D technology that offer 3D multi-user environments, known as "virtual worlds," that have interactive Avatars, rich media graphics, text chat, voice-to-voice chat, video and e-commerce. The 3D communities enable visitors to interact with each other, teleport throughout the Worlds environment, and participate in shared experiences.

Recently, Worlds announced that on January 14, 2020, the U.S. Patent Trial and Appeal Board (PTAB) issued a Notice that it dismissed three remaining Petitions for inter partes review, filed by Bungie, Inc., against patents owned by Worlds, Inc. in IPR Case Nos. 2015-01264, -01319, and -01321. In addition, the Board vacated its prior Decisions to Institute in these cases, and terminated the inter partes review proceedings initiated by Bungie without issuing final written decisions.

Mr. Thom Kidrin, Worlds' Chief Executive Officer, said, "We are pleased with the PTAB's decision to dismiss Bungie's remaining Petitions for inter partes review against Worlds' patents, thereby reinstating all of our claims in these cases. Worlds has had to endure the legal and financial gauntlet at the PTAB and Federal Circuit for over 4 ½ years while combating the challenges brought by Bungie, but we have ultimately prevailed with important claims intact in each challenged patent, and will return to the District Court in our case against Activision…”

Worlds, Inc. (WDDD), closed Thursday's trading session at $0.23, off by 11.5385%, on 104,440 volume with 17 trades. The average volume for the last 3 months is 105,304 and the stock's 52-week low/high is $0.159999996/$0.409900009.

chart

RenovaCare, Inc. (RCAR)

Micro Cap Daily, Zacks, Real Investment Advice, Last10k, OTC Markets, ResearchPool, Stockopedia, 4-Traders, Investors Hangout, Dividend Investor, StockInvest.us, Stockwatch, Stockhouse, Simply Wall St, TradingView, Wallet Investor, and GlobeNewswire reported beforehand on RenovaCare, Inc. (RCAR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

RenovaCare, Inc. is the developer of the SkinGun™ for spraying a patient’s own stem cells onto burns and wounds for accelerated self-healing. The Company is developing first-of-its-kind autologous (self-donated) stem cell therapies for the regeneration of human organs. A biotechnology enterprise, RenovaCare has its corporate headquarters in Scottsdale, Arizona. The Company lists on the OTC Markets.

RenovaCare’s first product under development targets the body’s largest organ, the skin. Its flagship technology, the CellMist™ System, utilizes its patented SkinGun™ to spray a liquid suspension of a patient’s stem cells – the CellMist™ Solution – onto wounds. The Company is developing its CellMist™ System as a promising new alternative for patients suffering from burns, chronic and acute wounds, and scars.

In investigative clinical use in the U.S., SkinGun™ treatments have shown the potential to naturally and quickly heal burns and other serious wounds. The CellMist™ System harvests a patient’s stem cells from a small area of skin, typically around 1 square inch. It suspends them in the water-based CellMist™ Solution. The suspension is delicately sprayed onto the wound utilizing the SkinGun™ deposition device, where it begins to grow new skin at the cellular level. The Company’s SkinGun™ spray device is the world’s most advanced technology of its type, as it uses a gentle positive-pressure air stream to spray the CellMist™ Solution onto wounds.

Recently, RenovaCare announced the appointment of Dr. Roger Esteban-Vives as Vice President of Research and Product Development. The appointment of Dr. Esteban-Vives follows a November 2018 equity financing of $15.5 million by Kalen Capital Corporation, wholly-owned by Mr. Harmel S. Rayat, the Company’s Chairman.

Furthermore, RenovaCare recently announced the appointment of Dr. Rodney L. Sparks as Vice President of Intellectual Property. Dr. Rodney Sparks is a respected intellectual property lawyer and technology licensing expert with decades of experience. In addition, he’s a regarded scientist with postdoctoral training from the Johns Hopkins University and a research fellowship from the Mayo Clinic.

RenovaCare also recently announced the appointment of Dr. Ben Walthall to its Advisory Board. Among other duties, Dr. Walthall will provide continuing support to Dr. Esteban-Vives in new product development and expanding the use of the RenovaCare technology platform for medical conditions beyond burns, including reconstructive surgery and cosmetic applications, including acne scarring, wrinkles, as well as tattoo removal.

RenovaCare, Inc. (RCAR), closed Thursday's trading session at $1.95, up 39.2857%, on 29,203 volume with 51 trades. The average volume for the last 3 months is 24,049 and the stock's 52-week low/high is $0.949999988/$4.48999977.

chart

Right On Brands, Inc. (RTON)

Penny Stock Hub, 4-Traders, InvestorsHub, Morningstar, Investors Hangout, SmallCapVoice, last10k, Interactive Brokers, MarketWatch, OTC Markets, Wallet Investor, YCharts, Simply Wall St, Barchart, Stockhouse, Capital Cube, Penny Stock Vault, Stockwatch, Stockopedia, and Investors News Magazine reported earlier on Right On Brands, Inc. (RTON), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Right On Brands, Inc. is a consumer goods company based in Santa Monica, California. It specializes in the brand development of health conscious, hemp-infused food and beverage products. Right On Brands consists of three subsidiaries. These are Endo Brands, Humble Water Company, and Humbly Hemp. Right On Brands’ shares trade on the OTC Markets.

The Company is developing, marketing, and investing in industrial hemp, cannabis, adaptogenic superfoods and natural water for a new generation of health-conscious consumers. Endo Water is pH balanced and micro-clustered for antioxidant protection. Additionally, Endo Water is oxygenated for improved performance and energy.

Endo Water is infused with a 99.5 percent pure CBD oil, processed using Nano Technology. This makes the particles one-millionth of its normal size. The process permits the Nano-Sized CBD's to immediately penetrate one’s cells versus the lengthy process of being absorbed by the body's digestive system.

Right On Brands created a joint venture (JV) with Centre Manufacturing, LLC to create ENDO Labs. ENDO Labs was established to fill the void in the hemp derived CBD market for the creation and manufacturing of quality formulated CBD products. ENDO labs can formulate food, beverage, skin-care/topical, supplements, and pet. It can also take on advanced formulations and products to any customers’ preference. ENDO Labs will also have the function of brokering CBD oil for its customers and clients. Right On Brands has 51 percent ownership of the JV with Medical Biochemist Dr. Ashok Patel's Centre Manufacturing.

Humbly Hemp is a product line of hemp-based products. Each Humbly Hemp bar is kosher, vegan, soy free, dairy free, and gluten-free. Furthermore, they are free of all top 11 allergens. The foundation of Right On Brands’ protein bars is with gluten free rolled oats, hemp seeds, and plant protein.

The Humble Water Company product is a natural spring water sourced from an ancient ice age aquifer at the foothills of the Rocky Mountains located at the only triple watershed in North America. Humble Water is pure and high in natural alkalinity.

Recently, Right on Brands announced it will be entering the lucrative health and wellness business with one of the Southwest's first full-service CBD based wellness centers. The corporate showcase ENDO Wellness Center is scheduled to open summer 2019 in Dallas, Texas. Right on Brands/Endo Brands, Inc, the maker of Endo Water will also be opening a regional distribution warehouse in Addison Texas on Midway Lane later this month.

Right On Brands, Inc. (RTON), closed Thursday's trading session at $0.0002, up 33.3333%, on 25,762,784 volume with 16 trades. The average volume for the last 3 months is 37,802,353 and the stock's 52-week low/high is $0.000099999/$0.07.

chart

DXI Energy, Inc. (DXIEF)

Stockfuse, MarketWatch, InvestorsHub, Zacks, Oilandgas360, Tip Ranks, Wallet Investor, Stock Digest, Amigo Bulls, Dividend Investor, Stockhouse, Private Capital News Wire, Stockwatch, Equity Clock, The Street, Barchart, Marketwired, YCharts, Capital Cube, Street Insider, Marketbeat, ValueForum, and Seeking Alpha reported on DXI Energy, Inc. (DXIEF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

DXI Energy, Inc. is a tactical acquisitor and developer of strategic energy resources. The Company is an upstream oil and gas exploration and production company. DXI Energy operates in Colorado’s Piceance Basin and in the Peace River Arch area in British Columbia  (B.C.). DXI Energy has offices in Calgary, Alberta, and Vancouver, British Columbia. The Company’s shares trade on the OTC Markets’ OTCQB.

In Colorado’s Piceance Basin, DXI Energy has 24,407 net acres.  In the Peace River Arch area in B.C. it has 13,093 net acres. Concerning its project areas, in the Piceance Basin in northwest Colorado, DXI has its Kokopelli project with 12 producing wells with extensive in place infrastructure to supplement future development as product prices dictate. 

The Company’s land holdings in the Piceance Basin highlight potential long-term regional resource value. This is as utilities develop sources of natural gas. For Kokopelli, DXI Energy retains a 25 percent Working Interest (WI) in 2,200 acres (550 net, 2 leases). 

In addition, DXI has its Roan Creek project (West Piceance Hi-Pressure Mancos/Niobrara Gas). This project is 1,960 net acres, 100 percent WI. There is potential development of 8-10 high pressure Mancos/Niobrara 8200’ vertical/Hz wells.

The Woodrush Project in northeastern B.C. encompasses 14,444 net acres (20.701 (gross) with 12 wells (3 oil and gas, 9 natural gas). DXI is the operator and it owns 99 percent of the Project. The Company has a multi-phase plan to expand production and landholdings at the Woodrush Project. It has $13mm invested in production facilities and a related network of pipelines at the Woodrush Project.

Recently, DXI Energy announced that it received all B.C. Oil & Gas Commission (BCOGC) permits to begin the drilling of a key Halfway formation exploration well at its Woodrush NE B.C. complex. Contracts for the building of road access and an environmentally modified drill pad meeting specs of all First Nation stakeholders were issued; construction is underway.

Chief Financial Officer, Mr. David Matheson, said, "With the permit to drill from the BCOGC (inclusive of all other stakeholders), we will now test the voracity of the Paradigm 3D seismic imaging and interpretation software with the drilling and completion of this important Woodrush Halfway pool test prior to winter 2019 break up."

DXI Energy, Inc. (DXIEF), closed Thursday's trading session at $0.0236, up 78.7879%, on 148,388 volume with 22 trades. The average volume for the last 3 months is 21,680 and the stock's 52-week low/high is $0.009399999/$0.077699996.

chart

FogChain Corp. (FOGCF)

StockReads, Stock Orange, Stockwatch, Bullish Guru, Penny Stock Hub, Press Reader, Investors Hangout, 4-Traders, OTC Markets, InvestorsHub, MarketWatch, Barchart, Insider Financial, Stockhouse, TradingView, Market Screener, and Wallet Investor reported previously on FogChain Corp. (FOGCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

FogChain Corp. is a completely integrated, end-to-end software development life cycle (SDLC) and quality assurance solutions provider. The Company’s set of services and technology provides application development at scale with more speed, efficiency and at a lesser cost. FogChain's Build-Once Deploy-Everywhere software architecture provides developers with a set of tools and resources that bridges devices, operating systems, and the ability to build and launch new applications in a unified environment. OTCQB-listed, FogChain is based in Vancouver, British Columbia.

FogChain has acquired RadJav, which provides developers with fast application development tools and resources for the creation of mobile and web apps, smart contracts, and dApps. These are to be used across all major operating systems and devices on a unified platform. In addition, FogChain also acquired Quilmont - a growing and profitable software development solutions provider specializing in automated testing, Continuous Integration and Deployment (CI/CD), mobile and website development, and software quality assurance.

Fundamentally, FogChain provides a next generation platform. This platform seamlessly integrates application development and deployment that leverages a high-performance Fog (or Edge) based computing network to drive scale and connects with the unique and ground-up built RadJav Blockchain. FogChain is introducing the next generation of decentralized compute to the world of software development and application lifecycle management.

RadJav has completed the integration of Visual Studio Code (VS Code) into its platform. The RadJav platform provides fast application development tools and resources to build and launch applications across all devices, from PCs to tablets and smartphones, and also operating systems such as Linux, Windows, Mac OSX, and Apple's iOS - all using the same code.

Fog Computing utilizes decentralized and distributed computing resources and application services that are closer to the Edge, or actual point of use. Fog Computing integrates with the most current technologies. These include IoT (Internet of Things), Blockchain, 3D & Virtual Reality engines, and analytics tools. It can leverage underused resources, reducing costs.

FogChain announced this past November that it commercialized and launched its Automated Application Testing Platform, Test Case Manager (TCM), an enterprise grade software application testing solution. TCM is a patented automated testing product. It enables organizations to accomplish substantial cost savings and improved time to market through automating their test cases.

FogChain also reached an agreement to acquire AppMark's application monitoring and benchmarking platform (AppMon) and other related assets for the issuance of one million shares and $40,000 USD. AppMark (Redwood City, California) is a SaaS solutions provider. It specializes in synthetic performance monitoring of enterprise mobile, web, as well as desktop applications.

Recently, FogChain announced it completed work on an initial release of Trident. This is a unified cross-platform application development, testing and monitoring services platform. Trident's Build-Once-Deploy-Everywhere software architecture provides developers with a group of tools to build, test, and monitor new applications using a single code-base while being natively deployed across desktop, tablet, and mobile devices.

Trident will feature the ability to deploy virtual testing labs across an array of web browsers and all major operating systems. The containerized approach permits companies to scale their development, testing, and monitoring processes with minimal effort and considerable cost savings.

FogChain Corp. (FOGCF), closed Thursday's trading session at $0.005, up 150.00%, on 100 volume with 1 trade. The average volume for the last 3 months is 558 and the stock's 52-week low/high is $0.000099999/$0.076800003.

chart

Northsight Capital, Inc. (NCAP)

Awesome Penny Stocks, OTC Markets, InvestorsHub, GuruFocus, Insider Monkey, Stockopedia, Equity Clock, Marketwired, The Street, Equities, MarketWatch, Barchart, WhaleWisdom, Stockhouse, Simply Wall St, and Uptick Newswire reported previously on Northsight Capital, Inc. (NCAP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Northsight Capital, Inc. consists of a portfolio of online Cannabis-related websites that are undergoing development and operated by the Company. These sites incorporate numerous facets of the Cannabis industry. The Company is transitioning into two sectors. One is the Bitcoin ATM service industry. The other is its modern cannabis advertising and media platform. Northsight Capital is headquartered in Scottsdale, Arizona.

Northsight Capital does not sell or distribute any cannabis products. The Company is looking to acquire digital or publishing companies in the space. It has its 420Careers.com. This is a leading job site in the Cannabis space.

Northsight Capital also has its WeedDepot.com. This website provides consumers with a geo-targeted map directory of medical and recreational dispensaries, head shops, doctors, attorneys and more within the Cannabis industry. Weed Depot has a whole platform of content suited for every aspect of advertising and marketing to consumers from all businesses in the cannabis industry.

Northsight Capital earlier acquired Crush Mobile, LLC. Crush Mobile has developed a group of dating sites with a presence in the Latino, Israeli, and African American communities. Crush Mobile is a part of the Company’s growing media group. Crush Mobile has incorporated into its dating applications suite Northsight Capital's "Joint Lovers" dating app that centers on the Cannabis space.

Northsight Capital reached an agreement in principal in 2018 to be the exclusive distributor of CBD products for SeniorsCBD, a brand of Seniors for CBD. Northsight Capital and Seniors for CBD signed an agreement in principal to create the first CBD product line specifically for the seniors’ market. Seniors for CBD (www.SeniorsforCBD.com) is a leader in the industry for educating and informing seniors on the continuing research on medical marijuana and CBD through bringing current news each day to their followers.

This past December, Northsight Capital announced that it launched its new enhanced cannabis careers web site, www.420Careers.com. This site first launched in 2010. It is considered one of the foremost career sites in the cannabis arena. The site has been updated with many new more user-friendly features. These features make it easier for job seekers to post their resumes and also makes it easier for employers to access them. The 420Careers site has 2,000 to 3,000 visitors a day and roughly 1 million-page views per month.

Recently, Northsight Capital announced an agreement in principal to be the master distributer of 3 exclusive lines of CBD products. The initial orders will be shipped early next month. The lines include earlier announced SeniorsCBD, specializing in formulas specifically for seniors, LiquidMD, a CBD infused water, LiquidMD for pets, and Nature Grown CBD, Northsight’s generic brand.

The Company is expecting to receive the initial shipment of its CBD products on or about the first week of March. First distribution will be through Northsight's broad online media presence and also independent sales and distribution outlets.

Northsight Capital, Inc. (NCAP), closed Thursday's trading session at $0.0012, up 33.3333%, on 314,000 volume with 2 trades. The average volume for the last 3 months is 272,993 and the stock's 52-week low/high is $0.000899999/$0.0052.

chart

Inspyr Therapeutics, Inc. (NSPX)

BUYINS.NET and Zacks reported earlier on Inspyr Therapeutics, Inc. (NSPX), and today we report on the Company, here at the QualityStocks Daily Newsletter.  

Inspyr Therapeutics, Inc. is a clinical-stage biotechnology company based in Westlake Village, California. It is developing novel prodrug therapeutics for the treatment of cancer. Mipsagargin is its lead agent. Mipsagargin is in human clinical trials for patients’ with numerous different tumor types. Inspyr Therapeutics’ team has considerable pharmaceutical industry and scientific experience.

The Company lists on the OTC Markets Group’s OTCQB. It previously went by the name GenSpera, Inc. It changed its name to Inspyr Therapeutics, Inc. in August of 2016.  

Mipsagargin (G-202) is a prodrug in human clinical trials for patients with hepatocellular carcinoma (HCC, or liver cancer), glioblastoma (GBM, or brain cancer) and prostate cancer. Mipsagargin has been studied in a Phase 2 clinical trial in patients with hepatocellular carcinoma (liver cancer). It has been granted Orphan Drug designation by the U.S. Food and Drug Administration (FDA) in this indication.  

Mipsagargin is now undergoing evaluation in an open-label, single-arm, Phase II clinical study in patients with glioblastoma (brain cancer). In addition, it is undergoing evaluation in two Phase II clinical pilot studies in patients with prostate and clear cell renal cancer.  

Inspyr Therapeutics has started the second development program for Mipsagargin as part of a combination therapeutic approach. This new program centers on the treatment of gastric cancer.

Inspyr has started a preclinical study in gastric cancer PDX tumor models that express varying levels of PSMA, the target of Mipsagargin. In this initial study, Mipsagargin will undergo evaluation initially in combination with paclitaxel.   

Inspyr Therapeutics is developing a novel technology platform. This platform combines a strong therapeutic (thapsigargin) with a patented prodrug delivery system that targets the release of drugs within solid tumors without the side effects of chemotherapeutic agents. This unique platform technology has the potential to work across a range of drugs that precisely target different cancers.       

In October of 2017, Inspyr Therapeutics announced the start of a new investigator-sponsored preclinical study of its proprietary adenosine receptor modulator (ARM) based compounds. The preclinical study is led by Elizabeth Kang, M.D., of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). This study will assess these compounds for the prevention of graft versus host disease (GvHD), a potential side effect of allogeneic stem cell transplants.

Inspyr Therapeutics, Inc. (NSPX), closed Thursday's trading session at $0.0026, up 36.8421%, on 9,101,019 volume with 116 trades. The average volume for the last 3 months is 2,117,196 and the stock's 52-week low/high is $0.0015/$0.197500005.

chart

PEN, Inc. (PENC)

DreamTeamNetwork, Outcast Traders, and SmallCapVoice reported earlier on PEN, Inc. (PENC), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, PEN, Inc. is an international leader in developing, commercializing, and marketing enhanced-performance products enabled by nanotechnology. PEN stands for Products Enabled by Nanotechnology. Products from its family of companies are for healthcare to homecare, homeland defense to food security, and transportation to recreation. PEN has its head office in Miami, Florida.

PEN is the combination of Nanofilm, Ltd. and Applied Nanotech Holdings, Inc. These are two nanotechnology innovators. PEN formed to channel the potential of nanotechnology in real-world products for real-world users. With the combination of these two companies, PEN provides nano-layer coatings, nano-based cleaners, as well as nano-composite products.

PEN’s Applied Nanotech, Inc. subsidiary is based in Austin, Texas. It functions as the Design Center conducting contract services for government and private customers and new product development for PEN centering on inventive and advanced product solutions in the areas of safety, health, and sustainability.

Applied Nanotech Holdings (the PEN Design Center) has over 25 years in the industry. It holds in excess of 250 patents. It has partnered with organizations like the U.S. Department of Transportation, the Army Research Office, and the U.S. Department of Agriculture to find nanotechnology-based solutions to challenges.

PEN, via its wholly-owned subsidiary PEN Brands LLC (formerly Nanofilm Ltd.), develops, manufactures, and sells products based on nanotechnology. This includes its Ultra Clarity® brand eyeglass cleaner, CLARITY DEFOG IT™ brand defogging products, CLARITY ULTRASEAL® nanocoating products for glass and ceramics, and an environmentally friendly surface protector, fortifier, and cleaner.

PEN, Inc. (PENC), closed Thursday's trading session at $1.45, up 45.00%, on 1,901 volume with 17 trades. The average volume for the last 3 months is 3,416 and the stock's 52-week low/high is $0.419999986/$3.24.

chart

The QualityStocks Company Corner

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced its plans to launch a new AI platform for vaccine and drug development targeting Coronaviruses and Acute Respiratory Syndromes (COVID-19, MERS and SARS) through an operating agreement with Soluble Therapeutics. To view the full press release, visit http://nnw.fm/RS3Nf

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Thursday's trading session at $2.28, up 6.5421%, on 16,237,362 volume with 68,200 trades. The average volume for the last 3 months is 169,860 and the stock's 52-week low/high is $1.93099999/$8.50.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioScience (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced its receipt of a purchase order from a new customer, Can B Corp. (OTCQB: CANBD). According to the update, the order is for one of PBIO’s proprietary BaroShear K45 Ultra Shear Technology(TM) ("UST")-based systems for processing CBD oil into stable, effectively water-soluble, highly absorbable nanoemulsions of oil in water. To view the full press release, visit http://cnw.fm/yRmn8. Also today, the company was highlighted in a publication from Financialnewsmedia.com, examining how the global nanoemulsion market is predicted to be one of the largest sub-markets in the cannabis industry, and experts project nanoemulsions to show a continued growth in the coming years. One industry expert company recently said that the nanoemulsion market is estimated to rise to $14.91 Billion by the end of 2025 and that other recent industry reports show that the recreational cannabis beverage industry is on the rise, and nanoemulsion-infused beverages are leading to the development of drinkable cannabis products that are both potent and fast acting.

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed Thursday's trading session at $1.70, off by 15.00%, on 23,423 volume with 39 trades. The average volume for the last 3 months is 19,716 and the stock's 52-week low/high is $0.600600004/$4.0300002.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) was featured today in the 420 with CNW by CannabisNewsWire. People have often assumed that marijuana consumers are lazy people with no future goals, and whose brain cells are slowly deteriorating. However, the reality is entirely the opposite, because while marijuana helps you relax when you are tired, you will find that some of the most famous and successful people in the world consume marijuana and this doesn’t detract from their productivity.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Thursday's trading session at $0.3664, off by 21.9263%, on 61,840 volume with 60 trades. The average volume for the last 3 months is 47,486 and the stock's 52-week low/high is $0.325414985/$4.67999982.

Recent News

chart

MCTC Holdings Inc. (OTC: MCTC)

The QualityStocks Daily Newsletter would like to spotlight MCTC Holdings Inc. (MCTC).

MCTC Holdings Inc. (OTC: MCTC) was featured today in a publication from CBDWire, examining how, when news of cannabidiol started filtering out, no one would have guessed the hemp extract would have gotten as popular as it has. Over the years, CBD has become more and more mainstream, culminating in the passing of the 2018 Farm Bill, legislation that legalized the cultivation and sale of industrial hemp and its extracts, including CBD. And in just a year of legal sales, CBD has grown quite a large market for itself, with experts estimating its worth will be $20 billion by 2024.

MCTC Holdings Inc. (OTC: MCTC) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June of 2019 and announced its intent to enter the cannabis sector and change its corporate identity to Cannabis Global Inc. The company is headquartered in Los Angeles, California.

With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://nnw.fm/v6RQ6).

Cutting-Edge Technology

MCTC is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.

The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://nnw.fm/cK3Bl):

  • Significantly improving bioavailability
  • Allowing for ultra-high loading rates
  • Enhancing customization of cannabinoid combinations
  • Improved dosing precision
  • Providing more control in release parameters

MCTC leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://nnw.fm/57Fjh). Recognizing the importance of IP, MCTC has been consistent in its application for patents to protect its innovative nanotechnology applications.

Patents

MCTC has now filed four patents on its cannabinoid delivery technology systems:

  • The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
  • Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
  • Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
  • Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.

Collaborations

MCTC collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market MCTC’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by MCTC. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).

Leadership

MCTC CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.

MCTC founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. (OTC: MCOA). He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at MCTC Holdings.

MCTC Holdings Inc. (MCTC), closed Thursday's trading session at $0.22, off by 12.00%, on 722 volume with 4 trades. The average volume for the last 3 months is 15,935 and the stock's 52-week low/high is $0.05/$3.00.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint, Inc. (SING) was featured today in a publication from HempWireNews, examining how, on March 28, a symposium on organic hemp and marijuana will be held to provide new and experienced farmers, producers, and growers with practical information and tools about the two industries. The symposium will be held at the (SIU) Southern Illinois University Carbondale Student Center’s Old Main Room.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Thursday's trading session at $0.006, off by 20.00%, on 8,050,404 volume with 274 trades. The average volume for the last 3 months is 4,085,374 and the stock's 52-week low/high is $0.004/$0.021999999.

Recent News

chart

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Wednesday announced that TerrAscend Canada Inc., a wholly owned subsidiary of CNPOF’s portfolio company TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF), has entered into an C$80.5 million loan financing arrangement with Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) pursuant to a secured debenture. To view the full press release, visit http://cnw.fm/2vXSL.

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (CNPOF), closed Thursday's trading session at $0.51021, off by 1.8827%, on 613,924 volume with 289 trades. The average volume for the last 3 months is 95,680 and the stock's 52-week low/high is $0.389999985/$3.53999996.

Recent News

chart

Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF)

The QualityStocks Daily Newsletter would like to spotlight Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF).

Willow Biosciences Inc. (TSX: WLLW; OTCQB: CANSF), is pleased to announce that it has achieved its first major commercial milestone by delivering a proprietary cannabinoid-producing yeast strain to its scale-up development partner, Albany Molecular Research, Inc. ("AMRI") to begin the process of scaling up production to commercial volumes.

Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) is a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates. The company’s cannabidiol (“CBD”) yeast-based biosynthesis program produces a high yield, ultrapure, low-cost and scalable manufacturing solution for pharmaceutical, food, beverage and personal care consumers of CBD.

The company is headquartered in Calgary, Alberta, Canada.

Biosynthesis Platform

Willow’s proprietary yeast-based lab strains produce CBD, tetrahydrocannabinol (“THC”), and cannabigerol (“CBG”), as well as certain minor and novel cannabinoids.

The company’s expertise in the esoteric field of biosynthesis and in delivering commercial fermentation pathways for the production of pharmaceutical-grade compounds grew from its origins in opiate research. Willow recently delivered a de novo biosynthesis pathway in yeast for thebaine, a key precursor API used as a feedstock in the manufacture of semi-synthetic opiates such as naloxone (used to reverse opioid overdose) and several common analgesics. Led by Chief Scientific Officer Dr. Peter Facchini, Willow’s research team discovered and patented numerous previously unknown genes coding for core catalytic pathway enzymes, as well as a number of additional non-pathway, yet commercially-essential, accessory genes.

Utilizing this proven synthetic biology platform, Willow’s research team has already begun producing cannabinoids at lab scale, using yeast as the host cell “factory.” This biosynthetic fermentation-based process is capable of producing pharmaceutical grade CBD in 10 days – far less time than traditional plant-based extraction methods.

Willow anticipates its technology can be scaled to produce hundreds of kilograms per batch of cannabinoid API at less than $1,000 per kilogram, thus costing approximately 60% less than current chemical synthesis methods and 90% less than conventional plant-based extraction methods.

World-Class Collaboration

Willow and Noramco Inc., the world’s largest producer of high-quality synthetic cannabinoid APIs and other controlled substance APIs for the pharmaceutical and healthcare industry, have an exclusive, worldwide Joint Development Agreement (“JDA”) to design a yeast-based biosynthesis platform for the production and distribution of a highly pure CBD isolate.

The mutually exclusive agreement calls for Willow to be responsible for optimizing yeast strains in a biosynthetic process to generate ultrapure CBD at high yield and substantially lower cost compared to current methods. Noramco will leverage its decades of experience in producing and delivering CBD and pharmaceutical APIs by being responsible for the scale-up, regulatory submission, marketing and distribution of products manufactured under the JDA.

Each company will invest comparable funds, will retain the intellectual property associated with their respective scopes of work and share equally in gross profits from sales of products manufactured under the JDA.

Market Opportunity

The agreement with Noramco (http://nnw.fm/Mz1vW) addresses the increasing demand for CBD-based APIs and other CBD-infused products by pharmaceutical, nutraceutical, consumer packaged goods, beverages and other industry sectors.

The U.S. market potential of cannabinoids is significant, with industry analysts projecting $50 billion in cannabinoid-based pharmaceutical sales and $16 billion in CBD consumer goods retail sales by 2025. As of June 2019, 34 U.S. states and the District of Columbia, Guam, Puerto Rico and U.S. Virgin Islands have legalized cannabis for medical use. Another 13 states and territories have approved recreational cannabis for adult use while other states are considering similar measures.

The cannabinoid API market continues to evolve with CBD and other cannabinoid-based treatment options currently in clinical trials for indications such as post-traumatic stress syndrome, epilepsy, Parkinson’s disease, chronic pain, schizophrenia, cancer treatments and other challenging unmet medical conditions.

Capitalization

Willow is fully funded after raising $29 million via private placement and $8 million in exercised warrants by Tuatara Capital Fund II, L.P. Proceeds of the funding will be used to enhance the existing laboratory space in Calgary and Vancouver, Canada, and in San Francisco, California. The company anticipates exiting 2020 with $15.8 million in cash.

Leadership

President and CEO Trevor Peters is an experienced executive who co-founded four startup companies in the past 15 years. He has raised over $1 billion in equity and debt financings at various stages of corporate development and has been integral to successful transactions totaling over $4 billion on sale. Mr. Peters previously was chief financial officer at Caracal Energy Inc., which sold to Glencore plc in 2014 for $1.8 billion.

Chief Financial Officer Travis Doupe has over 18 years of experience in financial leadership roles, principally in the international oil and gas industry, where he provided corporate strategic direction while overseeing all aspects of financial operations. Mr. Doupe is the treasurer and a member of the board of directors of the Canada Council for the Americas – Alberta and holds a CA-CPA designation and earned a bachelor’s degree in management from the University of Calgary.

Dr. Peter Facchini, Chief Scientific Officer, has been professor of plant biochemistry in the Department of Biological Sciences at the University of Calgary since 1995. He is recognized internationally as a leader in plant specialized metabolite biosynthesis. Dr. Facchini is the Canada Research Chair in Plant Metabolic Processes Biotechnology and has published more than 150 research papers and scholarly articles. Dr. Facchini received a PhD from the University of Toronto and conducted postdoctoral research at the University of Kentucky and Université de Montréal.

Dr. Joseph Tucker, Executive Chairman of the Board of Directors, holds more than 20 issued or pending patents and is a member of the Board of Directors of BioAlberta. He has extensive senior leadership experience in multiple public and private biotech companies. Dr. Tucker received a PhD in biochemistry and molecular biology from the University of Calgary.

Willow Biosciences Inc. (OTCQB: CANSF), closed Thursday's trading session at $0.427, even for the day, on 100 volume with 2 trades. The average volume for the last 3 months is 8,531 and the stock's 52-week low/high is $0.400999993/$2.1775.

Recent News

chart

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise and a commercial hemp enterprise, today announced that it is exploring the divestiture of its direct selling business unit back to the original founders of the direct selling division. To view the full press release, visit http://cnw.fm/Z5Owj

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed Thursday's trading session at $1.28, off by 2.2901%, on 165,632 volume with 1,467 trades. The average volume for the last 3 months is 90,501 and the stock's 52-week low/high is $1.07000005/$7.00.

Recent News

chart

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) today reported financial results for the fourth quarter and full year 2019. Foresight ended the fourth quarter of 2019 with $10.1 million in cash and short-term deposits. The Company reported GAAP net loss of $4.37 million for the fourth quarter of 2019, and non-GAAP net loss for the same period of $4 million.

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed Thursday's trading session at $0.61, off by 6.1683%, on 70,838 volume with 67 trades. The average volume for the last 3 months is 40,283 and the stock's 52-week low/high is $0.600000023/$2.94000005.

Recent News

chart

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF)

The QualityStocks Daily Newsletter would like to spotlight HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF).

HTC Extraction Systems (TSXV:HTC) (OTC:HTPRF) is pleased to announce that Todd Beasley, considered by our industry to be the "Grandfather" of solvent, ethanol and glycol extraction and purification systems in North America, has joined the HTC Extraction Systems team. Mr. Beasley brings over 30 years experience of purifying, glycols, ethanols and solvents to HTC.

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp biomass and cannabidiol (“CBD”) industry, as well as gas and liquid extraction. HTC’s extraction & purification systems are engineered to large-scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced.

Advanced Extraction Technologies

For more than 14 years, HTC has developed and optimized proprietary technology and purification systems used for biomass, gas and liquid extraction. These technologies include:

  • LCDesign® – Low-cost design for modular gas, liquid and biomass extraction systems optimizes plant design, thus reducing capital and operating costs.
  • PDOEngine™ – Software-based design algorithms accurately model and simulate gas, liquid and biomass extraction processing.
  • Delta Solvents™ – Custom-designed, ethanol-based solvent mixtures and additives that optimize production and reduce costs. Technology development is being conducted at HTC’s sponsored research facilities at the University of Calgary.

Delta Purification® Technology

HTC’s patented Delta Purification® technology will purify, recycle and reuse the extraction ethanol used in the CBD extraction process while managing and reducing any CBD waste losses through the re-extraction of all wastes collected from the purified ethanol. Current and new technologies include:

  • Delta CBD Reclaiming System: Reclaiming and purifying ethanol for use in CBD extraction from biomass. Reduces required heat to prevent damage of the chemical attributes of the CBD molecule, allowing extracted CBD to meet food-grade targets for human consumption.
  • Delta Solvent Reclaiming System: Reclaiming and purifying ethanol-based solvents, such as single, mixed and formulated amines, for use in natural gas processing and post-combustion CO2 capturing processes.
  • Delta Glycol Reclaiming System: Reclaiming and purifying glycols, such as mono-ethylene glycol and tri-ethylene glycol for use in natural gas dehydration processes.

Hemp Biomass and Tolling Contracts

HTC has entered into a hemp biomass tolling agreement for the 2019 crop year involving a supply of hemp biomass from a hemp grower in Saskatchewan, Canada. The hemp grower utilizes five varieties of Health Canada-approved cultivars as the genetic foundation. HTC will process and extract CBD FSO distillate from the hemp biomass. As a tolling fee payment, HTC will receive a percentage of the extracted CBD FSO distillate for its processing, extraction, purification and distillation services.

Additional hemp biomass tolling contracts with producers and hemp biomass providers are being negotiated in the U.S. for the 2020 hemp crop growing year. HTC will provide “local-to-grower” drying-to-biomass storage capability and transportation of dried biomass to an HTC, location to be determined, future US based, extraction facility. HTC is also in negotiation with a 60,000-acre, recognized Canadian farm leader, who is a significant hemp biomass producer, for a similar hemp biomass tolling contract.

re3™ Technology

Large users of ethanol and solvents for plant oil extraction demand reduced capital and operating costs. HTC’s re3™ (reclaim, recycle, reuse) technology can save up to 30% of the required fluid costs. The increasing cost of new extraction ethanol, combined with the cost of used ethanol disposal, creates a unique opportunity whereby the re3™ technology will create cost savings, while meeting environmental responsibilities.

The growth of ethanol and CO2 used in CBD production has created a new demand for reliable commercial scale ethanol reclaimer systems. The Delta Purification® ethanol system meets this new demand.

Sales and Offtake Agreements

HTC intends to leverage its relationship with its related entity, Purely Canada Foods™, to provide sales and distribution for its Ingredient CBD market under the brand of Purely Canada Hemp™, Purely Canada CBD™, Purely Canada Cannabinoids™. Purely Canada Hemp™ will develop risk managed multi-year ingredient supply contracts with its existing and new Global Food, Beverage and Animal Food Industry Customers.

Project Construction

HTC has focused the Canadian implementation of its BOOM (build, own, operate and maintain) extraction tolling strategy on a location near Regina, Saskatchewan. HTC is currently constructing a 19,000-square-foot GMP Euro compliant extraction tolling facility on six acres of land that will include biomass processing, extraction, implementation of DeltaSolv™ technologies and Delta Purification® systems, distillate and refining equipment, laboratory quality control and testing operations, and on-site office and admin facilities.

Leadership

Chairman, CEO and Director Lionel Kambeitz is a recognized professional in business development and international business relations. He has played a founding role in many other Canadian and U.S.-based companies. Kambeitz has executive experience in a variety of industries including energy, agriculture, food production engineering, and manufacturing.

Jeff Allison, Senior Vice President, Chief Financial Officer and Director, has over 20 years of experience in corporate finance and business development. Prior to joining HTC in 2005, Allison as Vice President assisted with the founding and setup of CUCORP Financial Services in Saskatchewan.

HTC Extraction Systems (OTCQB: HTPRF), closed Thursday's trading session at $0.06057, off by 6.8154%, on 300 volume with 1 trade. The average volume for the last 3 months is 536 and the stock's 52-week low/high is $0.060570001/$0.920000016.

Recent News

chart

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Petroteq Energy Inc. ‎‎(TSXV:PQE; ‎OTC:PQEFF; FSE:PQCF), an integrated oil ‎company focused on the development and implementation of its proprietary oil-‎extraction and remediation technologies, is pleased to announce progress on the licensing of its proprietary oil-sands extraction ‎technology.

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil sands exploration and production on mineral leases in Vernal, Utah, and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 2,500-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Clean Oil Recovery Technology (CORT) System.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ. PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy Chairman Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry.

“API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy Inc. (PQEFF), closed Thursday's trading session at $0.0425, off by 15.00%, on 1,562,475 volume with 96 trades. The average volume for the last 3 months is 325,827 and the stock's 52-week low/high is $0.031199999/$0.497599989.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade (OTCQB: SGMD), together with the BudCars Cannabis Delivery Service, today announced a sharp rise in demand for its cannabis delivery service, driving an associated 10% week-over-week rise in total sales over the past two weeks. According to the update, the company believes this dynamic is being driven by the stay-at-home trend that has emerged in many communities around the world in response to the global COVID-19 outbreak. To view the full press release, visit http://cnw.fm/r1l3I

Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6

Sugarmade, Inc. (SGMD), closed Thursday's trading session at $0.0041, off by 8.8889%, on 12,969,452 volume with 175 trades. The average volume for the last 3 months is 8.894,366 and the stock's 52-week low/high is $0.0023/$0.061.

Recent News

chart

National Storm Recovery Inc. (OTC: NSRI)

The QualityStocks Daily Newsletter would like to spotlight National Storm Recovery Inc. (NSRI).

National Storm Recovery Inc. (OTC: NSRI), through its subsidiaries, including National Storm Recovery, LLC (DBA Central Florida Arbor Care and Mulch Manufacturing, Inc.), provides tree services, debris hauling, removal and bio-mass recycling, manufacturing, packaging and sales of next-generation mulch products. The company’s primary corporate objective is to provide a solution for the treatment and handling of tree debris that is historically sent to local landfills and disposal sites, creating an environmental burden and pressure on disposal sites around the nation.

Environmentally Friendly

National Storm and the solutions provided by its Sustainable Green Team are founded in sustainability. The company’s vertically integrated operations begin with the collection of tree debris through its tree services division and collection sites. Tree bio-mass is then moved through the processing division for recycling and manufacturing into a variety of organic, attractive, next-generation mulch products to be packaged and sold to retailers, landscapers, installers and garden centers.

The company’s solutions create a synergistic and environmentally beneficial solution to tree and storm waste disposal that historically has created an environmental burden on landfills and disposal sites around the nation.

National Storm’s customers include governmental, residential and commercial customers and now big box retailers. The company is headquartered in Florida.

Strategic Acquisition

National Storm in February 2020 acquired 35-year-old industry leader and innovator Mulch Manufacturing, Inc., an Ohio corporation. Structured as a share exchange, this strategic partnership provides National Storm with a significantly larger footprint in the mulch industry.

The acquisition includes Mulch Manufacturing’s national and international distribution agreements, an increase in production and packaging capacity, and its sales contracts with numerous big box retailers. Mulch Manufacturing includes mulch production, sawmill operation, Natures Reflections colorant manufacturing and equipment manufacturing.

Next-Gen Products

National Storm’s vision and commitment to the environment is paired with Mulch Manufacturing’s revolutionary “next-generation” mulch product, Nature’s Reflection’s Softscape®.

Softscape mulch products, created from natural forest products, are color-enhanced with environmentally safe colorants to provide four-year color retention and are free from contaminants. Safe for people and pets, Softscape allows water and air to penetrate soil and roots, which is vital to plant health and growth.

Expansion Plans

National Storm plans to expand its operations through a combination of organic growth, through its partnership with a nationally recognized waste disposal company, and through strategic acquisitions that are both accretive to earnings and positioned for rapid growth from the resulting synergistic opportunities identified.

The company has received final zoning approval for its 100-acre site, located in Lake County, Astatula, Florida, which will serve as the company’s flagship tree debris collection site. The facility will also house the company’s mulch manufacturing, soil composting and production bagging. This prime location includes a 5,000-square-foot building that contains warehouse and office space. The 100-acre property can accommodate millions of cubic yards of organic debris and will allow National Storm’s debris hauling division to realize significant savings on its transportation costs.

National Storm has chosen as its new headquarters the Mulch Manufacturing 100,000-square-foot building in Jacksonville, Florida. The facility comprises centralized operations of Mulch Manufacturing, Inc. and National Storm Recovery, LLC, and has ample room to expand as the needed.

Leadership

National Storm’s Sustainable Green Team boasts more than 40 years of next-level experience with mulch manufacturing, treating and caring for trees. This team is guided by a roster of highly qualified professionals:

  • Tony Raynor, Chief Executive Officer
  • Edward Lee, Chief Operating Officer
  • Ralph Spencer, Director of Business Development, Strategic Acquisitions
  • Steve Ogden, ISA-Certified Arborist
  • Rick Starcher, Master Chemist
  • Peder K. Davisson, Esq., Corporate/Securities Counsel

National Storm Recovery Inc. (OTC: NSRI), closed Thursday's trading session at $0.50, up 25.00%, on 600 volume with 4 trades. The average volume for the last 3 months is 671 and the stock's 52-week low/high is $0.0982/$3.00.

Recent News

chart

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Sharing Services Global Corporation (SHRG), formerly Sharing Services Inc., is a diversified company dedicated to maximizing shareholder value, operating through two primary subsidiaries: Elepreneurs Holdings, a direct-selling company, and Elevacity Holdings, a products company. Headquartered in Plano, Texas, SHRG markets and distributes Elevate-branded health and wellness products through an independent sales force of distributors called Elepreneurs.

Proprietary Products

SHRG’s current exclusive Elevate product offerings are marketed under the Elevacity brand, so named to signify the company’s commitment to elevating lives.

The Elevate health and wellness product line consists of nutraceutical products that SHRG refers to as D.O.S.E., which stands for dopamine, oxytocin, serotonin and endorphins – all of which are key hormones proven to promote happiness and well-being.

Elevacity brand products are carefully formulated, chosen and designed to support a single objective: elevate the happiness and well-being of the consumer.

Global Network of Elepreneurs

Elevacity products are shared and sold by a growing international network of home-based entrepreneurs, called Elepreneurs, operated by Elepreneurs Holdings. This SHRG subsidiary provides basic and advanced programs for both new and experienced entrepreneurs who are focusing on their direct-sales careers.

SHRG’s high-performing independent sales force follows the company’s Blue Ocean selling strategy, an approach that encourages individuals to seek new markets, lead, and to “stop competing and start creating.” The Blue Ocean strategy is based on the book, “Blue Ocean Strategy,” written by Professor Renée Mauborgne, who notes that “the lesson here is that the best defense is offense, and the best offense… is to make a blue ocean shift and create your own blue ocean.”

Following this selling strategy, SHRG’s Elepreneurs are taught that, rather than competing directly in a competitive, direct-selling market, they should focus on making competitors irrelevant and succeeding in an uncontested marketplace.

In addition, SHRG’s Elepreneurs use the interactive, video-based VERB sales-marketing platform developed by Verb Technology Company Inc. The app utilizes proprietary interactive video data collection and analysis technology and provides next-generation customer relationship management, lead generation, and video marketing software applications.

Continued Momentum as Industry Leader

These selling strategies have resulted in sharp and consistent revenue gains. In the company’s 10-Q filed with the SEC for the three months ended Oct. 31, 2019, SHRG reported sales of $38.8 million for fiscal Q2 2019, an increase of 116% over sales of $17.9 million reported for the comparable quarter of 2018. Consolidated gross profit jumped by $16.2 million to $27.4 million for the same period compared to Q2 2018.

SHRG’s consolidated operating earnings were $3.9 million in the fiscal quarter ended Oct. 31, 2019, compared to $866,802 for the comparable period the prior year. Consolidated gross margin also grew 70.9% for the three months ended Oct. 31, 2019, compared to 62.2% the prior year.

These numbers are continuing a trend established over the past two years. In fiscal Q1 2019, SHRG achieved revenues of $35.4 million, more than double that of the comparable period in 2018. Even earlier, the company reported sales of $85.9 million for fiscal year ended April 30, 2019. This represents a nine-fold increase, or $77.5 million jump, over the company’s revenues of $8.4 million the prior year.

These numbers bring SHRG’s sales revenues since December 2017 — when the company’s Elevate product line was released — to an impressive cumulative total of $169 million.

Preparing for Success

SHRG is well prepared to continue and accommodate for this growth. The company recently expanded its corporate footprint by moving to a 10,000-square-foot facility in Plano, Texas, that offers ample room to expand as the company grows and flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

In addition, the company has a seasoned, expert leadership team in place, led by John “JT” Thatch. Thatch was appointed president and CEO of SHRG in March 2018, bringing to the company his expertise obtained from successfully starting, owning and operating several businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist SHRG as the company aims to expand and increase revenues.

Contact
469.304.9400 x 201
Info@SHRGinc.com
http://www.SHRGinc.com

Sharing Services Global Corporation (SHRG), closed Thursday's trading session at $0.053, up 32.50%, on 198,400 volume with 12 trades. The average volume for the last 3 months is 357,767 and the stock's 52-week low/high is $0.0215/$0.3944.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.